Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair

Molecular & Cellular Proteomics, 2016 · DOI: 10.1074/mcp.M115.057794 · Published: June 1, 2016

Spinal Cord Injury Genetics Bioinformatics

Simple Explanation

This study investigates the molecular events after spinal cord injury (SCI) using proteomics and imaging techniques. It focuses on how these processes differ across various spinal cord segments and time points post-injury. The research identifies specific molecular markers for each segment at different times (3, 7, and 10 days after SCI). Surprisingly, segments caudal (towards the tail) to the injury site show a strong inflammatory response alongside the production of neuroprotective molecules. The study also found immunoglobulins (IgGs) present at the injury site 3 days post-injury, which may hinder regeneration. Treating with anti-CD20 did not improve outcomes.

Study Duration

10 Days

Participants

Male Wistar rats

Evidence Level

Not specified

Key Findings

1
Molecular and cellular processes after SCI differ significantly between segments near the lesion (R1-C1) and those further away (R2-C2 and R3-C3).
2
The caudal segment immediately adjacent to the lesion site has intrinsic components that could allow axonal regeneration, but inhibitory signals hamper this potential.
3
Immunoglobulins (IgGs) are present at the lesion site only 3 days after injury, and anti-CD20 treatment did not reduce these antibodies or improve outcomes.

Research Summary

This study provides an exhaustive spatio-temporal proteomic and biochemical analysis performed along the entire spinal cord axis in a rat model of SCI. The researchers identified specific markers for each segment at different time points (3, 7, and 10 days), noting that caudal segments exhibited a robust inflammatory process alongside neuroprotective molecules. The study also found immunoglobulins (IgGs) present at the lesion site only 3 days after injury, and in vivo treatment with anti-CD20 did not diminish the presence of these antibodies nor ameliorate the BBB score.

Practical Implications

Therapeutic Targeting

Consider the C1 segment as a therapeutic target to modulate inflammation and stimulate regeneration.

Time-Specific Interventions

Develop time-specific therapeutic interventions based on the temporal kinetics of molecular events after SCI.

Personalized Treatment

Consider personalized treatment strategies that account for the specific molecular profile of different spinal cord segments.

Study Limitations

1
Study conducted on a rat model, findings may not directly translate to humans.
2
The study focuses on soluble factors, potentially overlooking other important aspects of SCI.
3
The effect of anti-CD20 treatment was assessed only at 3 days. A longer follow-up might reveal different results.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury